Study Evaluating Streptococcus Pneumoniae Serotype Carriage Rate for Nasopharyngeal Carriage in Filipino Children

Back to Search
Print
Bookmark Trial

NCT00724828

Last updated date
Back to Search
Print
Bookmark Trial
FOR MORE INFORMATION
Contact
1-800-718-1021
[email protected]
Related Links

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

By phone

Pfizer Clinical Trials Contact Center

1-800-718-1021

By email

Contact

[email protected]

Call Now

Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Bacterial Pneumonia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
2-5 months
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy children aged between 2 months and 5 years attending the well baby clinic in hospital.

- Informed consent obtained from parents or legal guardian.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

Call Now
pfizer-logoClinical Trials
Interested in learning more about clinical trials?
Discover how clinical trials work and the impact your participation could have.
Learn more ›

TRY A NEW SEARCH

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Advanced Search

Based on your search, you may also be interested in

Bacterial PneumoniaThe Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)
NCT01189487
  1. Seto-shi, Aichi-ken
  2. Kitakyushu, Fukuoka
  3. Kitakyushu, Fukuoka
  4. Yanagawa, Fukuoka
  5. Asahikawa, Hokkaido
  6. Sapporo, Hokkaido
  7. Himejishi, Hyogo
  8. Takamatsu, Kagawa
  9. Kawasaki-city, Kanagawa
  10. Yokohama, Kanagawa
  11. Koushi-shi, Kumamoto
  12. Shiogama, Miyagi
  13. Matsumoto, Nagano
  14. Isahaya, Nagasaki
  15. Nagasaki-city, Nagasaki
  16. Tsukubo-gun, Okayama
  17. Ureshino-shi, Saga
  18. Sayama, Saitama
  19. Hamamatsu, Shizuoka
  20. Fukuoka,
  21. Kochi,
  22. Kumamoto,
ALL GENDERS
16 Years+
years
MULTIPLE SITES
Bacterial PneumoniaA Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization
NCT00797108
  1. Chula Vista, California
  2. Chula Vista, California
  3. Oceanside, California
  4. Oceanside, California
  5. Moline, Illinois
  6. Rock Island, Illinois
  7. Minneapolis, Minnesota
  8. Akron, Ohio
  9. Akron, Ohio
  10. Akron, Ohio
  11. Provo, Utah
  12. Provo, Utah
  13. Brisbane, Queensland
  14. Hamilton, Ontario
  15. Hamilton, Ontario
  16. Hamilton, Ontario
  17. Seoul,
  18. Bialystok,
  19. Brzesko,
  20. Krakow,
  21. Lodz,
  22. Poznan,
  23. Proszowice,
  24. Warszawa,
ALL GENDERS
18 Years+
years
MULTIPLE SITES
Bacterial PneumoniaStudy Evaluating Streptococcus Pneumoniae Serotype Carriage Rate for Nasopharyngeal Carriage in Filipino Children
NCT00724828
ALL GENDERS
2 Months+
years
MULTIPLE SITES
Bacterial PneumoniaStudy Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia
NCT00707239
  1. Louisville, Kentucky
  2. Omaha, Nebraska
  3. Morgantown, West Virginia
  4. La Plata, Buenos Aires
  5. Godoy Cruz, Mendoza
  6. La Plata, Provincia de Buenos Aires
  7. Provincia de Buenos Aires,
  8. Nambour, Queensland
  9. Victoria,
  10. Belo Horizonte, MG
  11. Porto Alegre, RS
  12. Sao Jose do Rio Preto, SP
  13. Chicoutimi, Quebec
  14. Trois-Rivieres, Quebec
  15. Santiago,
  16. Medellin, Antioquia
  17. Bogota,
  18. Zagreb,
  19. Argenteuil,
  20. Debrecen,
  21. Nyiregyhaza,
  22. Szekesfehervar,
  23. Vac,
  24. Seoul, Korea
  25. Seoul, Korea
  26. Seoul, Korea
  27. Seoul, Korea
  28. Daugavpils,
  29. Riga,
  30. Riga,
  31. Moscow,
  32. Moscow,
  33. Novosibirsk,
  34. St Petersburg,
  35. St Petersburg,
  36. Vsevolozhsk,
  37. Tainan,
  38. Tainan,
  39. Taipei TOC,
  40. Taipei,
ALL GENDERS
18 Years+
years
MULTIPLE SITES
Advanced Information
Descriptive Information
Brief Title Study Evaluating Streptococcus Pneumoniae Serotype Carriage Rate for Nasopharyngeal Carriage in Filipino Children
Official Title An Evaluation of Streptococcus Pneumoniae Serotype Carriage Rate For Nasopharyngeal Carriage in Filipino Children Attending Well Baby Clinic in Hospitals and Primary Care Centers
Brief Summary Evaluation of the carriage rate of Streptococcus pneumoniae in the nasopharynx of healthy children and the carriage rate and distribution of Streptococcus pneumoniae serotypes
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population Primary care clinic
Condition Pneumonia, Bacterial
Intervention Not Provided
Study Groups/Cohorts 1
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: July 29, 2008)		500
Original Actual Enrollment Same as current
Actual Study Completion Date November 2005
Actual Primary Completion Date November 2005   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Healthy children aged between 2 months and 5 years attending the well baby clinic in hospital.
  • Informed consent obtained from parents or legal guardian.
Sex/Gender
Sexes Eligible for Study:All
Ages 2 Months to 5 Years   (Child)
Accepts Healthy Volunteers Yes
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number NCT00724828
Other Study ID Numbers 0887X-101959
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth
Study Sponsor Wyeth is now a wholly owned subsidiary of Pfizer
Collaborators Not Provided
Investigators
Study Director:Medical MonitorWyeth is now a wholly owned subsidiary of Pfizer
PRS Account Wyeth is now a wholly owned subsidiary of Pfizer
Verification Date July 2008